Target Audience:
Nurse practitioners and physician assistants involved in the management of patients with GI disorders and chronic liver disease.
Statement of Need:
The objective of the "Best of GHAPP" Regional Meetings is to discuss an in-depth review and discussion on the latest developments and important current concepts in the multidisciplinary treatment of patients with GI disorders and chronic liver disease.
Educational Objectives:
Upon completion of this educational activity, participants should be able to:
ANCC Accreditation:
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 4.0 contact hours may be earned for successful completion of this activity.
This activity is approved for 4.0 contact hours which includes 2.25 hour(s) of pharmacology. Program ID #5922.
AAPA Accreditation:
Disclosure of Conflicts of Interest:
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower and GHAPP have no relationships to disclose.
Learner Assurance Statement:
The ACHS is committed to mitigating all conflict of interest issues that could arise as a result of individuals who control activity content and who have relationships with ACCME-defined ineligible companies. The ACHS is committed to retaining only those individuals with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
This activity is supported by educational grants from: AbbVie, Dova Pharmaceuticals, Inc., Ferring Pharmaceuticals, Inc., Intercept Pharmaceuticals, Inc., Janssen Biotech, Inc., QOL Medical, LLC., and Salix Pharmaceuticals.
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Gastroenterology and Hepatology Advanced Practice Providers.